IPAB revokes Allergan eye drug patent

12-08-2013

IPAB revokes Allergan eye drug patent

On August 8 the Indian Intellectual Property Appellate Board (IPAB) revoked another patent owned by a Western pharmaceutical company – this time related to Allergan’s eye drug Combigan.


IPAB, Allergan, Combigan, Ajanta Pharma

LSIPR